133 related articles for article (PubMed ID: 3006486)
1. Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.
Mayer KH; Ayotte D; Groopman JE; Stoddard AM; Sarngadharan M; Gallo R
Am J Med; 1986 Mar; 80(3):357-63. PubMed ID: 3006486
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
3. Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features.
Bienzle U; Guggenmoos-Holzmann I; Zwingenberger K; Thommsen R; Ritter K; Uy A; Bayer H; Schneider J; Hunsmann G; Coester CH
Klin Wochenschr; 1985 Jul; 63(13):597-602. PubMed ID: 2993734
[TBL] [Abstract][Full Text] [Related]
4. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
[TBL] [Abstract][Full Text] [Related]
5. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
6. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M
Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729
[TBL] [Abstract][Full Text] [Related]
7. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
[TBL] [Abstract][Full Text] [Related]
8. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.
Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR
Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men.
Mayer KH; Stoddard AM; McCusker J; Ayotte D; Ferriani R; Groopman JE
Ann Intern Med; 1986 Feb; 104(2):194-6. PubMed ID: 3004277
[TBL] [Abstract][Full Text] [Related]
11. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
13. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
[TBL] [Abstract][Full Text] [Related]
14. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
15. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.
Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC
Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878
[TBL] [Abstract][Full Text] [Related]
16. Diversity of clinical spectrum of HTLV-III infection.
Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
[TBL] [Abstract][Full Text] [Related]
17. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.
Jaffe HW; Darrow WW; Echenberg DF; O'Malley PM; Getchell JP; Kalyanaraman VS; Byers RH; Drennan DP; Braff EH; Curran JW
Ann Intern Med; 1985 Aug; 103(2):210-4. PubMed ID: 2990275
[TBL] [Abstract][Full Text] [Related]
18. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
19. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
Abb J
Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
[TBL] [Abstract][Full Text] [Related]
20. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study.
Melbye M; Biggar RJ; Ebbesen P; Neuland C; Goedert JJ; Faber V; Lorenzen I; Skinhøj P; Gallo RC; Blattner WA
Ann Intern Med; 1986 Apr; 104(4):496-500. PubMed ID: 3006568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
